A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: Part II

Jose De Leon, Neil B. Sandson, Kelly L. Cozza

Research output: Contribution to journalArticlepeer-review

35 Scopus citations
Original languageEnglish
Pages (from-to)347-361
Number of pages15
JournalPsychosomatics
Volume49
Issue number4
DOIs
StatePublished - 2008

Bibliographical note

Funding Information:
In the past year, Dr. de Leon has been on the advisory board of Roche Molecular Systems, Inc. He has received investigator-initiated grants from Roche Molecular Systems, Inc. , and Eli Lilly Research Foundation ; he has lectured supported by Eli Lilly, Janssen, and Roche Molecular Systems, Inc. Roche Molecular Systems, Inc. , markets the AmpliChip CYP450 microarray that detects CYP2D6 and CYP2C19 gene variations.

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Applied Psychology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: Part II'. Together they form a unique fingerprint.

Cite this